Spatial Transcriptomics Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
39
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Spatial Transcriptomics General Information
Description
Developer of innovative technology solutions to analyze tissue samples and gene expression data in two dimensions. The company's solution allows RNA sequencing in 2D, visualizing gene expression in its morphological context.
Contact Information
Website
www.spatialtranscriptomics.comCorporate Office
- Södra Fiskartorpsvägen 15 C
- 114 33 Stockholm
- Sweden
Corporate Office
- Södra Fiskartorpsvägen 15 C
- 114 33 Stockholm
- Sweden
Spatial Transcriptomics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Spatial Transcriptomics Comparisons
Industry
Financing
Details
Spatial Transcriptomics Competitors (7)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Genotypic Technology | Corporation | Bengaluru, India | ||||
HTG Molecular Diagnostics | Formerly VC-backed | Tucson, AZ | ||||
2D Genomics | Corporation | Fremont, CA | ||||
Nucleome Informatics Pvt | Corporation | Hyderabad, India | ||||
Advanced Cell Diagnostics | Formerly VC-backed | Minneapolis, MN |
Spatial Transcriptomics Patents
Spatial Transcriptomics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230115903-A1 | Stabilization and/or compaction of nucleic acid molecules | Pending | 03-Aug-2021 | ||
US-20230037182-A1 | Circularizable probes for in situ analysis | Pending | 30-Jul-2021 | ||
US-20230035685-A1 | One step in situ rolling circle amplification assay | Pending | 30-Jul-2021 | ||
US-20230041485-A1 | Methods and compositions for synchronizing reactions in situ | Pending | 30-Jul-2021 | ||
US-20230031305-A1 | Compositions and methods for analysis using nucleic acid probes and blocking sequences | Pending | 30-Jul-2021 | C12Q1/6816 |
Spatial Transcriptomics Signals
Spatial Transcriptomics Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Spatial Transcriptomics FAQs
-
When was Spatial Transcriptomics founded?
Spatial Transcriptomics was founded in 2012.
-
Who is the founder of Spatial Transcriptomics?
Jonas Frisén, Joakim Lundeberg, and Patrik Ståhl are the founders of Spatial Transcriptomics.
-
Where is Spatial Transcriptomics headquartered?
Spatial Transcriptomics is headquartered in Stockholm, Sweden.
-
What is the size of Spatial Transcriptomics?
Spatial Transcriptomics has 39 total employees.
-
What industry is Spatial Transcriptomics in?
Spatial Transcriptomics’s primary industry is Biotechnology.
-
Is Spatial Transcriptomics a private or public company?
Spatial Transcriptomics is a Private company.
-
What is Spatial Transcriptomics’s current revenue?
The current revenue for Spatial Transcriptomics is
. -
Who are Spatial Transcriptomics’s investors?
Seven Bridges Genomics has invested in Spatial Transcriptomics.
-
Who are Spatial Transcriptomics’s competitors?
Genotypic Technology, HTG Molecular Diagnostics, 2D Genomics, Nucleome Informatics Pvt, and Advanced Cell Diagnostics are some of the 7 competitors of Spatial Transcriptomics.
-
When was Spatial Transcriptomics acquired?
Spatial Transcriptomics was acquired on 10-Dec-2018.
-
Who acquired Spatial Transcriptomics?
Spatial Transcriptomics was acquired by 10x Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »